Robert Woods
Patrimonio netto: 3 M $ in data 30/06/2026
Patrimonio netto: 3 M $ in data 30/06/2026
Attualmente, R. Keith Woods ricopre la posizione di Chief Operating Officer di argenx SE. Nella sua carriera passata ha ricoperto la posizione di SVP-North American Operations presso Alexion Pharmaceuticals, Inc. e di vicepresidente e amministratore delegato presso Alexion Pharma UK Ltd. (una filiale di Alexion Pharmaceuticals, Inc.). (una filiale di Alexion Pharmaceuticals, Inc.). Si è laureato alla Florida State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 16/04/2026 | 48.034 ( 0,04% ) | 3 M $ | 30/06/2026 | |
| 09/06/2025 | 6.000 ( 0,01% ) | 28 020 $ | 30/06/2026 | |
-.--% | 07/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| 20/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 06/12/2023 |
| SCHOLAR ROCK HOLDING CORPORATION | Direttore operativo | 27/04/2025 |
| Società | Posizione | Fine |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 22/08/2025 |
| ROCKET PHARMACEUTICALS, INC. | Direttore operativo | 18/06/2025 |
| ARGENX SE | Corporate Officer/Principal | 01/06/2023 |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Distribution Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale